Treatment of hemophilia: Recombinant factors only? No

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 2, 2003, Pages 216-217

  Mannucci, P M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Factor IX; Factor VIII; Hemophilia

Indexed keywords

BLOOD CLOTTING FACTOR; RECOMBINANT PROTEIN;

ARTICLE; DISEASE TRANSMISSION; HEMOPHILIA A; HUMAN; ISOLATION AND PURIFICATION; ITALY; SAFETY; VIRUS INFECTION;

BLOOD COAGULATION FACTORS; HEMOPHILIA A; HUMANS; ITALY; RECOMBINANT PROTEINS; SAFETY; VIRUS DISEASES;

EID: 0141785315     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00046.x     Document Type: Note

References (8)

1. Santagostino E, Mannucci PM. Guidelines on replacement therapy for haemophilia and inherited coagulation disorders in Italy. Haemophilia 2000; 6: 1-10.
2. Azzi A, Morfini M, Mannucci PM. The transfusion-associated transmission of parvovirus B19. Transfus Med Rev 1999; 13: 194-204.
3. Mannucci PM, Chediak J, Hanna W, Byrnes J, Ledford M, Ewenstein BM, Retzios AD, Kapelan BA, Schwartz RS, Kessler C. Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study. Blood 2002; 99: 450-6.
4. Tabor E. The epidemiology of virus transmission by plasma derivatives. clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1. Transfusion 1999; 39: 1160-8.
5. Hunter N, Foster J, Chong A, McCutcheon S, Parnham D, Eaton S, MacKenzie C Houston F. Transmission of prion diseases by blood transfusion. J General Virol 2002; 83: 2897-905.
6. Stenland CJ, Lee DC, Brown P, Petteway SR Jr, Rubenstein R. Partitioning of human and sheep forms of the pathogenic prion protein during the purification of therapeutic proteins from human plasma. Transfusion 2002; 42: 1497-5000.
7. National Hemophilia Foundation. Medical Advisory West Nile Virus # 392 and 393. eNews@hemophilia.org, 2002.
8. Tarantino MD, Novale LM, Bray GL, Ewenstein BM. Clinical evaluation of a new generation recombinant FVIII, plasma/albumin-free method (rAHF-PFM). Blood 2002; 100: 493a.